<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05056818</url>
  </required_header>
  <id_info>
    <org_study_id>2020-0974</org_study_id>
    <secondary_id>NCI-2021-08879</secondary_id>
    <secondary_id>2020-0974</secondary_id>
    <nct_id>NCT05056818</nct_id>
  </id_info>
  <brief_title>Comparison of Synthetic Mammography Versus Full-Field Digital Mammography in Image Interpretation and Performance Metrics</brief_title>
  <official_title>Comparison of Synthetic Mammography Versus Full-Field Digital Mammography in Image Interpretation and Performance Metrics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>M.D. Anderson Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>M.D. Anderson Cancer Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study compares synthetic mammography to full-field digital mammography in image&#xD;
      interpretation and performance metrics. Digital breast tomosynthesis (DBT) has previously&#xD;
      been found to be superior in performance to standard digital mammography in both screening&#xD;
      and diagnostic settings for the early detection and improved diagnosis of breast cancers. DBT&#xD;
      in combination with full-field digital mammography (FFDM) reduces recall rates and increases&#xD;
      cancer detection rates relative to FFDM alone. Synthetic mammography is a 2-dimensional&#xD;
      reconstructed image, using the dataset derived from the DBT acquisition, without requiring&#xD;
      additional radiation dose. Collecting information from patients' medical records may help&#xD;
      doctors analyze the characteristics, utility, and impact of synthetic mammography to compared&#xD;
      to FFDM.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVE:&#xD;
&#xD;
      I. To analyze the characteristics, utility, and impact of synthetic mammography (SM), as&#xD;
      compared with full-field digital mammography (FFDM).&#xD;
&#xD;
      OUTLINE:&#xD;
&#xD;
      Patients' medical records and past imaging examinations are reviewed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 15, 2020</start_date>
  <completion_date type="Anticipated">October 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To analyze the impact of synthetic mammography (SM), as compared with full-field digital mammography (FFDM</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Breast Carcinoma</condition>
  <arm_group>
    <arm_group_label>Observational (medical records)</arm_group_label>
    <description>Patients' medical records and past imaging examinations are reviewed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Electronic Health Record Review</intervention_name>
    <description>Review of medical records and past imaging examinations</description>
    <arm_group_label>Observational (medical records)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who have undergo mammography between August 1, 2018 and August 31, 2020&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Female&#xD;
&#xD;
          -  Age 18 or older&#xD;
&#xD;
          -  Consecutive cases in breast imaging center&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Cases demonstrate administrative or technical errors (e.g. missing views, labeling&#xD;
             inconsistent with report, etc.)&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ray C Mayo</last_name>
    <role>Principal Investigator</role>
    <affiliation>M.D. Anderson Cancer Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>M D Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ray C. Mayo</last_name>
      <phone>713-745-4555</phone>
      <email>rcmayo@mdanderson.org</email>
    </contact>
    <investigator>
      <last_name>Ray C. Mayo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mdanderson.org</url>
    <description>M D Anderson Cancer Center</description>
  </link>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 1, 2021</study_first_submitted>
  <study_first_submitted_qc>September 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 27, 2021</study_first_posted>
  <last_update_submitted>September 15, 2021</last_update_submitted>
  <last_update_submitted_qc>September 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

